Metraipolis › archive › dc_b6fef5073d72

Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol — Europe PMC PMID:41481895

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41481895
DOI
10.1097/hc9.0000000000000839
License (as archived)
solo-consultazione
Archived
2026-11-01T09:34:24.687Z
SHA-256 of the archived text
dbe2fb288fd71abfd1724253e865a2a1feda75acfbfdd30040f61e84637ac755
Stable URL of this page
https://metraipolis.com/documento/dc_b6fef5073d72

How to cite

Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol — Europe PMC PMID:41481895 — Europe PMC (en), https://europepmc.org/article/MED/41481895 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6fef5073d72 (Metraipolis archive dc_b6fef5073d72, sha256 dbe2fb288fd71abfd1724253e865a2a1feda75acfbfdd30040f61e84637ac755)
BibTeX
@misc{dcb6fef5073d72,
  title = {Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol — Europe PMC PMID:41481895},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41481895},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6fef5073d72; sha256 dbe2fb288fd71abfd1724253e865a2a1feda75acfbfdd30040f61e84637ac755},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41481895. Agents can read the archived copy with the MCP tool read_document.